Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

ASH 2024

7 - 10 Dec 2024
San Diego Convention Center, San Diego, United States of America
Videos
News
ASH 2024: Discovery of gene linked to high-altitude adaptation may transform blood cancer care
ASH 2024: Discovery of gene linked to high-altitude adaptation may transform blood cancer care
ASH 2024: Longer-term data for asciminib reinforce superior efficacy with favourable safety and tolerability profile in adults with newly diagnosed CML
ASH 2024: Longer-term data for asciminib reinforce superior efficacy with favourable safety and tolerability...
ASH 2O24: Early signs of efficacy for a novel drug and a new predictive tool to guide patient care
ASH 2O24: Early signs of efficacy for a novel drug and a new predictive tool to guide patient care
ASH 2024: Prospective study finds social and economic factors limit access to stem cell transplants for patients with AML
ASH 2024: Prospective study finds social and economic factors limit access to stem cell transplants for patients...
ASH 2024: Study finds genetic changes, elevated leukaemia risk in ground zero first responders
ASH 2024: Study finds genetic changes, elevated leukaemia risk in ground zero first responders
ASH 2024: High response rate, manageable adverse effects seen with epcoritamab in pretreated R/R CLL
ASH 2024: High response rate, manageable adverse effects seen with epcoritamab in pretreated R/R CLL
ASH 2024 - Multi-center study shows education level, income impact access to stem cell transplantation for acute myeloid leukaemia patients
ASH 2024 - Multi-center study shows education level, income impact access to stem cell transplantation for acute...
ASH 2024: Combining BCL-2 and BTK inhibitors shows promise in CLL
ASH 2024: Combining BCL-2 and BTK inhibitors shows promise in CLL
ASH 2024: Anitocabtagene autoleucel demonstrates 97% ORR and 62% CR/sCR in relapsed or refractory multiple myeloma
ASH 2024: Anitocabtagene autoleucel demonstrates 97% ORR and 62% CR/sCR in relapsed or refractory multiple myeloma
ASH 2024: Combination of two oral agents improves progression-free survival in previously untreated chronic lymphocytic leukaemia
ASH 2024: Combination of two oral agents improves progression-free survival in previously untreated chronic...
ASH 2024: Belantamab mafodotin shows significant OS benefit, reducing risk of death by 42% in multiple myeloma at or after first relapse
ASH 2024: Belantamab mafodotin shows significant OS benefit, reducing risk of death by 42% in multiple myeloma at...
ASH 2024: Daratumumab cuts risk of progression by half in smouldering multiple myeloma
ASH 2024: Daratumumab cuts risk of progression by half in smouldering multiple myeloma
ASH 2024: Could venetoclax improve outcomes of CAR T for patients with resistant B-cell lymphomas?
ASH 2024: Could venetoclax improve outcomes of CAR T for patients with resistant B-cell lymphomas?
ASH 2024: Preclinical study shows targeted drug strengthens the power of CAR T-cell therapy in two paediatric leukaemias
ASH 2024: Preclinical study shows targeted drug strengthens the power of CAR T-cell therapy in two paediatric...
ASH 2024: Study reveals how venetoclax boosts immune response to CAR T for chronic lymphocytic leukaemia
ASH 2024: Study reveals how venetoclax boosts immune response to CAR T for chronic lymphocytic leukaemia
ASH 2024 - A fibre-rich diet may help prevent complications after stem cell transplant
ASH 2024 - A fibre-rich diet may help prevent complications after stem cell transplant
ASH 2024 - Smoking linked with genetic mutations that worsen myelodysplastic syndromes
ASH 2024 - Smoking linked with genetic mutations that worsen myelodysplastic syndromes
ASH 2024 - High-fibre diet may slow disease progression to multiple myeloma
ASH 2024 - High-fibre diet may slow disease progression to multiple myeloma
ASH 2024 - Resistance training can reduce fatigue, pain in multiple myeloma patients
ASH 2024 - Resistance training can reduce fatigue, pain in multiple myeloma patients
ASH 2024: Ketogenic diet boosts CAR T-Cell function for better tumour control
ASH 2024: Ketogenic diet boosts CAR T-Cell function for better tumour control

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation